Decentralized Clinical Trials (DCTs) Industry Research Report 2023
Number of Pages: 92
Category: Healthcare and Medical
Country: Tibet
Format:
Published Date: 08 Aug 2023
The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
Highlights
The global Decentralized Clinical Trials (DCTs) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).
The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Product Type Insights
Global markets are presented by Decentralized Clinical Trials (DCTs) type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Decentralized Clinical Trials (DCTs) are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Decentralized Clinical Trials (DCTs) segment by Type
Interventional
Observational
Expanded Access
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Decentralized Clinical Trials (DCTs) market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Decentralized Clinical Trials (DCTs) market.
Decentralized Clinical Trials (DCTs) Segment by Application
Oncology
Cardiovascular
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Decentralized Clinical Trials (DCTs) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trials (DCTs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trials (DCTs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Decentralized Clinical Trials (DCTs) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trials (DCTs).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Decentralized Clinical Trials (DCTs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
Highlights
The global Decentralized Clinical Trials (DCTs) market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).
The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Product Type Insights
Global markets are presented by Decentralized Clinical Trials (DCTs) type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Decentralized Clinical Trials (DCTs) are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Decentralized Clinical Trials (DCTs) segment by Type
Interventional
Observational
Expanded Access
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Decentralized Clinical Trials (DCTs) market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Decentralized Clinical Trials (DCTs) market.
Decentralized Clinical Trials (DCTs) Segment by Application
Oncology
Cardiovascular
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Decentralized Clinical Trials (DCTs) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decentralized Clinical Trials (DCTs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Decentralized Clinical Trials (DCTs) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Decentralized Clinical Trials (DCTs) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decentralized Clinical Trials (DCTs).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Decentralized Clinical Trials (DCTs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
What factors will challenge the Product Name market growth?
Which end-use segment will expand at the fastest CAGR in the Product Name market?
Which are the emerging players in the Product Name market?
How concentrated is the Product Name market?
Which factors are positively contributing to the Product Name market growth?
Which are the novel product innovations in the Product Name market?
Which product segment will emerge as the most lucrative in the Product Name market?
Which factors are increasing the competition in the Product Name market?
Which are the strategic measures taken by the Product Name industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Product Name market in the coming years?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Decentralized Clinical Trials (DCTs) by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
2.3 Decentralized Clinical Trials (DCTs) by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Oncology
2.3.3 Cardiovascular
2.3.4 Others
2.4 Assumptions and Limitations
3 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
3.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2018-2023)
3.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2023-2028)
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2018-2023)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2018-2029)
5.2 Global Decentralized Clinical Trials (DCTs) Growth Trends by Region
5.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2018-2023)
5.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2024-2029)
5.3 Decentralized Clinical Trials (DCTs) Market Dynamics
5.3.1 Decentralized Clinical Trials (DCTs) Industry Trends
5.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
5.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
5.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
6.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2018-2023)
6.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2018-2023)
6.2 Global Decentralized Clinical Trials (DCTs) Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Decentralized Clinical Trials (DCTs) Head office and Area Served
6.4 Global Decentralized Clinical Trials (DCTs) Players, Product Type & Application
6.5 Global Decentralized Clinical Trials (DCTs) Players, Date of Enter into This Industry
6.6 Global Decentralized Clinical Trials (DCTs) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
7.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
7.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
8.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
8.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
9.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
9.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
10.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
10.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
11.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
11.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Medidata
11.1.1 Medidata Company Detail
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Detail
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Detail
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Detail
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Detail
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Detail
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Detail
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Detail
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.11.5 Science 37 Recent Development
13 Report Conclusion
14 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Decentralized Clinical Trials (DCTs) by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
2.3 Decentralized Clinical Trials (DCTs) by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Oncology
2.3.3 Cardiovascular
2.3.4 Others
2.4 Assumptions and Limitations
3 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
3.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2018-2023)
3.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2023-2028)
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2018-2023)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2018-2023)
5 Global Growth Trends
5.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2018-2029)
5.2 Global Decentralized Clinical Trials (DCTs) Growth Trends by Region
5.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2018-2023)
5.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2024-2029)
5.3 Decentralized Clinical Trials (DCTs) Market Dynamics
5.3.1 Decentralized Clinical Trials (DCTs) Industry Trends
5.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
5.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
5.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
6.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2018-2023)
6.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2018-2023)
6.2 Global Decentralized Clinical Trials (DCTs) Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Decentralized Clinical Trials (DCTs) Head office and Area Served
6.4 Global Decentralized Clinical Trials (DCTs) Players, Product Type & Application
6.5 Global Decentralized Clinical Trials (DCTs) Players, Date of Enter into This Industry
6.6 Global Decentralized Clinical Trials (DCTs) Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
7.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
7.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 Europe
8.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
8.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
8.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
9.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
9.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 Latin America
10.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
10.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
10.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
11.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
11.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 Players Profiled
11.1 Medidata
11.1.1 Medidata Company Detail
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Detail
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Detail
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Detail
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Detail
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Detail
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Detail
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Detail
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2017-2022)
11.11.5 Science 37 Recent Development
13 Report Conclusion
14 Disclaimer